The provision of appropriate nutritional support is an essential part of the primary and adjunctive management of many gastrointestinal (GI) disorders in neonatology and pediatrics. Few conditions in neonatology pose as great a challenge as intestinal failure or short bowel syndrome (SBS). The latter, SBS, is a complex disorder affecting normal intestinal physiology with nutritional, metabolic and infectious consequences. It is a result of the alteration of intestinal digestion and absorption following extensive bowel resection. Medical management of SBS is a very labor-intensive problem. Nutritional support and monitoring are of paramount importance, and long-term morbidity and mortality will depend on recognition and careful management of associated complications. With the increased use of intestine or intestine-liver transplant, maintaining these infants in good 'health' to allow transplantation will go a long way in achieving good long-term outcomes.
Introduction
The provision of appropriate nutritional support is an essential part of the primary and adjunctive management of many gastrointestinal (GI) disorders in neonatology and pediatrics. Few conditions in neonatology pose as great a challenge as intestinal failure or short bowel syndrome (SBS). The latter, SBS, is a complex disorder affecting normal intestinal physiology with nutritional, metabolic and infectious consequences. It is a result of the alteration of intestinal digestion and absorption following extensive bowel resection. Frequently, a shortened or resected colon also is involved in the pathogenesis of diarrhea. However, essential to the SBS is the loss of surface area in the small intestine, which diminishes the capacity to digest and absorb dietary nutrients.
Historically, infants who underwent massive bowel resection as a result of various intra-abdominal disease conditions were given little hope of survival. With the advent of total parenteral nutrition, specialized infant and pediatric formulas for enteral nutrition, and now, intestinal transplantation, these infants survive and to a large extent may grow and develop normally.
Physiology and pathophysiology
The small intestine is approximately 250 cm in length in a term neonate, compared with 600 to 800 cm in an adult. 1 This translates to a mucosal surface area of 950 cm 2 in an infant and 7500 cm 2 in an adult. During fetal development, approximately 120 cm of the small bowel is present in the second trimester of pregnancy and it doubles in length during the third trimester. Therefore, it stands to reason that potential intestinal growth after resection is more favorable in infants and children compared with adults. However, mucosal surface area is not uniform throughout the small intestine, with approximately one-half of the mucosal surface being contained within the proximal fourth of the small intestine. In healthy infants, absorption of fluids and nutrients occurs throughout the length of the small intestine, with more of it being in the proximal bowel. The duodenum and jejunum are the main sites for the absorption of carbohydrate, protein and fat. Iron, calcium, copper, water and fat-soluble vitamins are also absorbed in the proximal small bowel. The distal small bowel is involved in the absorption of intrinsic factor-bound vitamin B 12 and the active transport of conjugated bile salts. The jejunum allows for a rapid flux of water and electrolytes, whereas the ileum acts as a functional reserve for substances not absorbed proximally, including efficient water absorption. Colonic absorption reduces fluid and electrolytes losses as well. Common causes of SBS are listed in Table 1.   2 The management of infants with SBS depends on the basic understanding of normal GI physiology, the effects of loss of specific portions of bowel and the ensuing intestinal adaptation that occur. Factors that influence intestinal function in SBS include the following: total remaining small-intestinal length; etiology of loss; timing of loss (before or after birth); remaining intestine (jejunum, ileum and so on); presence or absence of the ileocecal valve and the length of time after loss of intestine. A loss of 50% of the small bowel length, depending on the gestational age, can be generally well tolerated if the remainder of the bowel functions normally. The degree of ensuing malabsorption is dependent on the lost surface area and intestinal functional reserve. The latter is exemplified by the fact that the neonatal intestine has the potential to grow and therefore increase in length compared with adults. The more distal the loss of intestine, the more severe the accompanying effects and morbidity. For example, loss of the proximal small bowel is associated with both fat and carbohydrate malabsorption, in particular, and almost all nutrients in general. The intestine in an infant has a greater potential than adults to increase in length after resection, and therefore, adaptation may be better. Removal of the stomach, jejunum or colon is well tolerated than loss of the ileum. However, the effects observed are dependent on the loss, as illustrated by the stomach reacting to massive loss of intestine by increasing gastric output; this hypergastrinemia is possibly because of the loss of an inhibitor or reduced carbohydrate absorption. 3, 4 It is usually self-limited, decreasing after weeks to months. In addition, it can also cause diarrhea causing further malabsorption of fats, starches and protein. With the loss of jejunum, carbohydrate absorption is decreased, as well as that of protein, fat, vitamins (except B 12 ), minerals and water. Bacterial action on the unabsorbed carbohydrate can lead to the production of lactic acid, thereby leading to metabolic acidosis. Fat malabsorption may lead to formation of insoluble calcium soaps, which decrease calcium absorption. Loss of the ileum impairs vitamin B 12 absorption, although the length of time it takes for vitamin B 12 levels to fall is very variable. 5 The loss of ileum also disrupts bile salt recirculation. 6 The loss of unabsorbed bile salts is initially compensated for by increased hepatic synthesis; bile salts that reach the colon undergo deconjugation by colonic bacteria; the deconjugated bile salts stimulate water and ion secretion and stimulate colonic motility. 7, 8 Excess fecal secretion of bile salts depletes the bile acid pool, impairs fat absorption and increases steatorrhea. Loss of the large intestine has minimal effects on digestion and absorption. However, presence of the colon increases absorption of fluids, sodium, and excretion of potassium and bicarbonate. Another factor to be considered is the transit time of nutrients in the remaining bowel. This is determined by the length of the remaining bowel, presence or absence of the ileocecal valve and the amount of malabsorbed luminal contents. The shorter the transit time, the less the digestion and absorption of nutrients.
The concept of intestinal failure relates to inability in maintaining protein-energy, electrolyte and micronutrient balance that may occur due to many causes including obstruction, dysmotility, surgical resection, congenital defect or a loss of absorption. Thus, an infant with SBS may have intestinal failure, whereas not all infants with intestinal failure have SBS.
The key to survival after bowel resection is the ability of the residual bowel to adapt. Intestinal adaptation begins within 48 h after resection and continues for many months afterwards. The adaptation may be a result of increased epithelial cell number, increased rate of enterocyte proliferation, increased depth of crypts and increased villus height. These functions are stimulated by enteral nutrients as lack of enteral nutrients induces intestinal hypoplasia. 9 Functionally, adaptation may occur because of increased disaccharidase activity, increased absorption of nutrients and increased colonic absorption of short-chain fatty acids. The latter results from bacterial fermentation of carbohydrate to yield short-chain fatty acids, principally, acetate, propionate and butyrate. There are several hormonal influences through prostaglandin E2, polyamine synthesis, gastrin, epidermal growth factor, growth hormone, glutamine, glucagon-like peptide-2 and long-chain polyunsaturated fatty acids that also lead to adaptation and are beyond the scope of this paper.
Principles of medical management
The loss of absorptive surface and mucosal enzyme reserve has a major role in consideration of medical management. Intestinal adaptation begins within 48 h of resection and may continue for at least 12 to 18 months postoperatively. Bowel lengthening and an increase in both bowel diameter and thickness are the changes that follow. Mucosal hyperplasia leads to increased villus height and crypt depth. However, the degree of hyperplasia is proportional to the length of small bowel lost. 10 The hyperplasia appears maximal near the anastomosis and is greater in the proximal than in the distal bowel. The hyperplasia is stimulated by enteral nutrients and this fact is often lost in clinical management. As lack of enteral nutrients causes intestinal hypoplasia, it is our practice to provide enteral nutrients after 'clearance' from the surgical colleagues and establishment of a stooling pattern. If there is malabsorption and resultant losses from the GI tract, minimal feeds are provided to maintain gut stimulation. The reversal of functional impairment caused by hypoplasia by enteral feeds has been shown in human and animal studies.
Initial medical management aims at replacement of fluids and electrolytes and initiation of total parenteral nutrition. Infants with enterostomies should have electrolytes and minerals measured serially, as they may require replacement beyond the usual recommendations. Enteral feeding can be provided either by the oral or by the nasogastric route. The frequency of feedings and amounts depend on the length of the remaining intestine. Continuous feeds appear to be more effective in infants with a massive loss of intestine. 11 It should be pointed out that if feeds are not provided orally, non-nutritive sucking should be encouraged to avoid oral aversion as this is often seen in these infants. The choice of feeding requires understanding of the effects of the intestine lost. As there is a loss of absorptive surface and reduced mucosal enzyme reserve, attention to the nutrient substrates being fed is important. For example, lactose is poorly absorbed in SBS because of relative lactase deficiency. Sucrosecontaining formulas are also not a good choice, as for every unit of lactase activity there are 2 units of sucrose activity; however, there are 6 to 8 units of maltase activity. 12 Therefore, maltase-containing formulas will provide better absorption of starches and glucose polymers, which are commonly added to infant and pediatric formulas. Glucose can be absorbed without the need for hydrolysis, but will raise the osmolality of the formula, making it problematic in an infant already present in a malabsorptive state. The malabsorbed carbohydrates present a large load to the colon, causing frequent, large watery stools.
Fat intake needs to be limited in infants with SBS as they are already burdened with depletion of bile salts and reduced pancreatic enzyme release. In addition, bacterial contamination/ translocation also contributes to fat malabsorption. Long-chain fatty acids are not well absorbed in the small intestine, thus making formulas containing medium-chain triglycerides, which are better absorbed and do not need micellar solubilization, a better choice of fat. Long-chain fatty acids do have an advantage as they contribute to small bowel adaptation, and a formula containing a combination of long-chain triglycerides and medium-chain triglycerides with a low total fat content is a better choice and is well tolerated.
Protein, on the other hand, is well tolerated and the hydrolyzed proteins appear to be better absorbed than whole proteins. Oligopeptides (2 to 5 amino acids) are handled well by the peptidases. Free amino-acid formulas do not need hydrolysis. Their disadvantage is the increased osmolar load, but their advantage is the presence of glucose polymers, and limited fat. Thus, elemental formulas are based on free individual amino acids and semi-elemental formulas have peptides of varying lengths, simple sugars, starches or glucose polymers, and fat as medium-chain triglycerides. A few of the formulas used in the management of SBS are listed in Table 2 .
Another category of formulas not usually used is the specialized formulas containing glutamine or arginine, nucleotides or essential fatty acids. In general, elemental and semi-elemental formulas are expensive, but are used because they are better absorbed and tolerated, considered less allergenic and have less of pancreatic stimulation. The elemental formulas are absorbed across the small-intestinal mucosa into the portal vein in the absence of bile salts or lipases. They require minimal digestive action and, as stated, cause less stimulation of exocrine pancreatic secretion. The semi-elemental formulas contain proteins that are hydrolyzed into oligopeptides, di-and tri-peptides. The latter have specific transport mechanisms and are absorbed efficiently. 13, 14 In addition, casein hydrolysates also stimulate jejunal water and electrolyte absorption.
In general, a formula containing hydrolysates, medium-chain triglycerides and glucose polymers appears to be a good initial choice for infants with SBS. It is controversial whether a full-strength (small volume) or diluted formula (larger volume) is the appropriate choice. Nonetheless, formula feeding, whether concentration or volume, can be advanced as tolerated. If feeding intolerance occurs, a free amino-acid formula should be used. In addition, supplements of fat and water-soluble vitamins need to be given when total parenteral nutrition is discontinued. Following loss of ileum, particular attention needs to be paid to vitamin B 12 , although deficiency may take many months to emerge. Iron supplementation is also important as infants with proximal small bowel loss are at risk for iron-deficiency anemia. It should be remembered that loss of zinc, copper and sodium can occur with diarrhea and may need supplementation. Other adjuncts to medical management include the use of cholestyramine or cholestipol, both of which are anion-exchange resins that can bind excessive bile salts, thus improving bile acid-induced diarrhea. Care should be taken to avoid excessive depletion of bile acids, which can exacerbate fat malabsoprtion. Loperamide increases gut transit time. Ranitidine has been used in infants with hypergastrinemia. Somatostatin has been used with limited success. Ursodeoxycholic acid is added to increase the bile-salt pool to ameliorate concomitant direct hyperbilirubinemia.
The complications associated with SBS are listed in Table 3 . Our approach is as follows: Attempt the same formula or human milk feeding. If dumping occurs (traditionally defined as 40% of the intake), switch to a semi-elemental ready-to-feed. If not tolerated, use an amino-acid formula. We use ursodeoxycholic acid once nearly full feeds are established.
Survival from SBS depends on the ability of the residual bowel to adapt. Morbidity and mortality depend on the extent and site of bowel resection, adaptive changes in the remaining bowel, presence or absence of the ileocecal valve, and the associated complications from total parenteral nutrition, including infection and hepatic dysfunction. The severely affected infants may require long-term home total parenteral nutrition.
In summary, medical management of SBS is a very laborintensive problem. Nutritional support and monitoring are of paramount importance and long-term morbidity and mortality will depend on recognition and careful management of associated complications. With the increased use of intestine or intestineliver transplant, maintaining these infants in good 'health' to allow transplantation will go a long way in achieving good long-term outcomes. 
